FDA official logo
GSRS logoPFDA official logo

NAXITAMAB

UNII:9K8GNJ2874
Formula:
Preferred Substance Name:NAXITAMAB

  • 1879925-92-4
  • ANTI-GD2 IGG3 MONOCLONAL ANTIBODY 3F8 HUMANIZED
  • ANTI-GD2 MONOCLONAL ANTIBODY 3F8 HUMANIZED
  • DANYELZA
  • HU3F8
  • HUMANIZED 3F8
  • HUMANIZED ANTI-GD2 MONOCLONAL ANTIBODY 3F8
  • HUMANIZED MONOCLONAL ANTIBODY HU3F8-IGG1
  • IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMANIZED MUS MUSCULUS CLONE HU3F8 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MUS MUSCULUS CLONE HU3F8 LIGHT-CHAIN, DIMER
  • IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS BETA-1,4 N-ACETYLGALACTOSAMINYLTRANSFERASE 1 ((N-ACETYLNEURAMINYL)-GALACTOSYLGLUCOSYLCERAMIDE, GM2/GD2 SYNTHASE))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (MUS MUSCULUS VH (IGHV2-9*02 (79%) (IGHD)-IGHJ3*01 (92%)) (8.6.13) (1-119)-HOMO SAPIENS IGHG1*01 (CH1(K97>R(216)) (120-449)) (222-211')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-211') (MUS MUSCULUS V-KAPPA (IGKV6-32*02 (85%) IGKJ2*03 (90%))(6.3.6)) (1'-104')-HOMO SAPIENS IGKC*01 (105'-211')), DIMER (228-228'':231-231'')-BISDISULFIDE
  • MONOCLONAL ANTIBODY HU3F8
  • NAXITAMAB [INN]
  • NAXITAMAB [USAN]
  • NAXITAMAB [WHO-DD]
  • NAXITAMAB GQGK [WHO-DD]
  • NAXITAMAB-GQGK



UNII - 9K8GNJ2874 | UNII Search Service